Related Experiment Video
Updated: Sep 22, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Reducing Daytime Sedation While Preserving Motor Function in Parkinson's Disease Psychosis: A Case Report of
1Psychiatry, Summa Health, Akron, USA.
Abstract:
Psychosis and behavioral dysregulation in advanced Parkinson's disease (PD) are commonly managed with psychotropic medications that may worsen motor symptoms or contribute to excessive daytime sedation. We describe a 77-year-old male with advanced PD and psychosis admitted following agitation-related self-removal of a percutaneous endoscopic gastrostomy (PEG) tube. Collateral history revealed persistent morning somnolence that limited participation in physical therapy and daily care activities. His medication regimen included multiple agents with sedating properties, raising concern for cumulative pharmacologic burden contributing to impaired daytime function. A structured approach to medication adjustments was implemented, focusing on selective deprescribing, consolidating sedating medications to evening dosing, and simplifying the overall regimen. Following iterative medication adjustments, agitation improved without escalation of standing psychotropic medications. Morning alertness improved, with increased participation in therapy sessions, while motor function remained stable. This case highlights an individualized approach to balancing behavioral control, daytime alertness, and motor preservation in PD psychosis while illustrating how cumulative sedative burden and medication timing may influence functional outcomes.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Therapy
Antianxiety Medications

